Importer of Controlled Substances Application: Arizona Department of Corrections, 39077 [2021-15710]
Download as PDF
Federal Register / Vol. 86, No. 139 / Friday, July 23, 2021 / Notices
that the United States did not pursue.
Microsoft, 56 F.3d at 1459–60.
In its 2004 amendments to the APPA,
Congress made clear its intent to
preserve the practical benefits of using
judgments proposed by the United
States in antitrust enforcement, Public
Law 108–237 § 221, and added the
unambiguous instruction that ‘‘[n]othing
in this section shall be construed to
require the court to conduct an
evidentiary hearing or to require the
court to permit anyone to intervene.’’ 15
U.S.C. 16(e)(2); see also U.S. Airways,
38 F. Supp. 3d at 76 (indicating that a
court is not required to hold an
evidentiary hearing or to permit
intervenors as part of its review under
the Tunney Act). This language
explicitly wrote into the statute what
Congress intended when it first enacted
the Tunney Act in 1974. As Senator
Tunney explained: ‘‘[t]he court is
nowhere compelled to go to trial or to
engage in extended proceedings which
might have the effect of vitiating the
benefits of prompt and less costly
settlement through the consent decree
process.’’ 119 Cong. Rec. 24,598 (1973)
(statement of Sen. Tunney). ‘‘A court
can make its public interest
determination based on the competitive
impact statement and response to public
comments alone.’’ U.S. Airways, 38 F.
Supp. 3d at 76 (citing Enova Corp., 107
F. Supp. 2d at 17).
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–861]
Importer of Controlled Substances
Application: Arizona Department of
Corrections
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Arizona Department of
Corrections has applied to be registered
as an importer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 23, 2021. Such persons
may also file a written request for a
hearing on the application on or before
August 23, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
VIII. Determinative Documents
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
There are no determinative materials
or documents within the meaning of the Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
APPA that were considered by the
Attn: DEA Federal Register
United States in formulating the
Representative/DPW, 8701 Morrissette
proposed Final Judgment.
Drive, Springfield, Virginia 22152.
Dated: July 14, 2021
SUPPLEMENTARY INFORMATION: In
Respectfully submitted,
accordance with 21 CFR 1301.34(a), this
is notice that on June 7, 2021, Arizona
For Plaintiff United States of America:
lllllllllllllllllllll Department of Corrections, 1305 E Butte
Avenue, ASPC-Florence, Florence,
REBECCA VALENTINE* (D.C. Bar #989607),
Arizona 85132–9221, applied to be
Trial Attorney,
registered as an importer of the
Defense, Industrials, and Aerospace Section,
Antitrust Division, 450 Fifth Street NW, Suite following basic class(es) of controlled
substance(s):
8700, Washington, DC 20530, Telephone:
khammond on DSKJM1Z7X2PROD with NOTICES
[FR Doc. 2021–15728 Filed 7–22–21; 8:45 am]
Drug
code
Controlled substance
Pentobarbital ....................
BILLING CODE 4410–11–P
Schedule
I 2270 I II
The facility intends to import the
above-listed controlled substance for
legitimate use. This particular
controlled substance is not available for
the intended legitimate use within the
current domestic supply of the United
States. No other activity for this drug
code is authorized for this registration.
VerDate Sep<11>2014
16:49 Jul 22, 2021
Jkt 253001
PO 00000
Frm 00108
Fmt 4703
Sfmt 4703
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
SUMMARY:
(202) 476–0432, Facsimile: (202) 514–9033,
Email: rebecca.valentine@usdoj.gov.
*Lead Attorney To Be Noticed
39077
[FR Doc. 2021–15710 Filed 7–22–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OMB Number 1121–0334]
Agency Information Collection
Activities; Proposed Collection
Comments Requested; Reinstatement,
With Change, of a Previously
Approved Collection for Which
Approval Has Expired: 2021 Survey of
Campus Law Enforcement Agencies
(SCLEA)
Office of Justice Programs,
Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), Office of Justice Programs,
Bureau of Justice Statistics, will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection
was previously published in the Federal
Register, Volume 86, Number 94, page
26944 on Tuesday, May 18, 2021,
allowing a 60-day comment period.
Following publication of the 60-day
notice, BJS did not receive any
comments on the proposed information
collection.
DATES: Comments are encouraged and
will be accepted for 30 days until
August 23, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
SUMMARY:
E:\FR\FM\23JYN1.SGM
23JYN1
Agencies
[Federal Register Volume 86, Number 139 (Friday, July 23, 2021)]
[Notices]
[Page 39077]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15710]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-861]
Importer of Controlled Substances Application: Arizona Department
of Corrections
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Arizona Department of Corrections has applied to be registered
as an importer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before August 23, 2021.
Such persons may also file a written request for a hearing on the
application on or before August 23, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on June 7, 2021, Arizona Department of Corrections, 1305
E Butte Avenue, ASPC-Florence, Florence, Arizona 85132-9221, applied to
be registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Pentobarbital........................... 2270 II
------------------------------------------------------------------------
The facility intends to import the above-listed controlled
substance for legitimate use. This particular controlled substance is
not available for the intended legitimate use within the current
domestic supply of the United States. No other activity for this drug
code is authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-15710 Filed 7-22-21; 8:45 am]
BILLING CODE P